Danaher Corporation (DHR) Fundamentals — Income, Balance Sheet & Cash Flow | MarketCI

Danaher Corporation (DHR) Fundamentals — Income, Balance Sheet & Cash Flow | MarketCI | MarketCI

DHR

Market Closed

Danaher Corporation

NYSEHealthcare Medical - Diagnostics & Research

61.00K employees

CEO: Rainer Blair

Founded: 1978

$177.17

+$0.00(+NaN%)

Market Cap

125.40B

Beta

0.83

52W Range

N/A

Dividend Yield

0.77%

Overview Forecasts Fundamental Market Sentiment Valuation Ownership

Financial Statements

Comprehensive breakdown of financial statements and performance metrics

Gross Margin

60.9%

5.4%

CAGR: -4.4%

Profit after direct costs

Operating Margin

20.9%

-0.9%

CAGR: -10.6%

Core business profitability

Net Margin

14.7%

-7.3%

CAGR: -13.4%

Bottom line profitability

Revenue Growth

2.9%

YoY

CAGR: -4.4%

Top line growth rate

Revenue Flow Analysis

Visual flow showing how DHR allocates revenue across expenses and profit

Fiscal Year 2025

Revenue Distribution

Flow of revenue through cost categories to net income

Gross Margin

60.9%

$14.97B

Operating Margin

20.9%

$5.14B

Net Margin

14.7%

$3.61B

Detailed Income Statement

Complete profit and loss breakdown with margin analysis and historical comparison

Item	2021	2022	2023	2024	2025	YoY Change
Total Revenue	29.45B	26.64B	23.89B	23.88B	24.57B	2.9%
Cost of Revenue	(11.50B)	(10.46B)	(9.86B)	(9.67B)	(9.60B)	-0.7%
Gross Profit	17.95B	16.19B	14.03B	14.21B	14.97B	5.4%
Operating Expenses
Research & Development	(1.74B)	(1.53B)	(1.50B)	(1.58B)	(1.60B)	0.9%
Selling, General & Administrative	(8.16B)	(7.12B)	(7.25B)	(7.44B)	(8.23B)	10.7%
Depreciation & Amortization	(2.17B)	(2.13B)	(2.17B)	(2.35B)	(2.45B)	4.0%
Operating Income (EBIT)	8.05B	7.54B	5.28B	5.18B	5.14B	-0.9%
Non-Operating Items
Interest Income	11.00M	41.00M	303.00M	117.00M	30.00M	-74.4%
Interest Expense	(241.00M)	(207.00M)	(289.00M)	(278.00M)	(265.00M)	-4.7%
Other Income/Expenses (Net)	-452.00M	-390.00M	-235.00M	-538.00M	-904.00M	68.0%
Income Before Tax	7.60B	7.15B	5.04B	4.65B	4.23B	-8.9%
Income Tax Expense	(1.25B)	(818.00M)	(823.00M)	(747.00M)	(619.00M)	-17.1%
Net Income	6.43B	7.21B	4.76B	3.90B	3.61B	-7.3%
Per Share Metrics
Earnings Per Share (Basic)	$9	$10	$6	$5	$5	-4.9%
Weighted Avg Shares Outstanding	714.60M	725.10M	736.50M	731.00M	707.30M	-3.2%
Weighted Avg Shares Outstanding (Diluted)	736.80M	737.10M	743.10M	737.20M	711.00M	-3.6%
EBITDA	10.01B	9.48B	7.50B	7.28B	6.95B	-4.5%

Explore DHR

Overview

Key metrics and AI-powered insights

Forecast

Price targets and earnings estimates

Fundamentals

Income, balance sheet and cash flow

Valuation

P/E, DCF and valuation multiples

Ownership

Institutional and insider holdings

Sentiment

Analyst ratings and news sentiment

DHR in the Healthcare

Large Cap

Healthcare

Browse sector stocks →

Medical - Diagnostics & Research

Browse industry stocks →